Works by Gallamini, Andrea

Results: 61
    1
    2
    3

    Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
    By:
    • Hutchings, Martin;
    • Radford, John;
    • Ansell, Stephen M.;
    • Illés, Árpád;
    • Sureda, Anna;
    • Connors, Joseph M.;
    • Sýkorová, Alice;
    • Shibayama, Hirohiko;
    • Abramson, Jeremy S.;
    • Chua, Neil S.;
    • Friedberg, Jonathan W.;
    • Kořen, Jan;
    • LaCasce, Ann Steward;
    • Molina, Lysiane;
    • Engley, Gerald;
    • Fenton, Keenan;
    • Jolin, Hina;
    • Liu, Rachael;
    • Gautam, Ashish;
    • Gallamini, Andrea
    Publication type:
    Article
    4

    Early serum TARC reduction predicts prognosis in advanced‐stage Hodgkin lymphoma patients treated with a PET‐adapted strategy.

    Published in:
    Hematological Oncology, 2020, v. 38, n. 4, p. 501, doi. 10.1002/hon.2775
    By:
    • Viviani, Simonetta;
    • Mazzocchi, Arabella;
    • Pavoni, Chiara;
    • Taverna, Francesca;
    • Rossi, Andrea;
    • Patti, Caterina;
    • Romano, Alessandra;
    • Trentin, Livio;
    • Sorasio, Roberto;
    • Guidetti, Anna;
    • Gottardi, Daniela;
    • Tarella, Corrado;
    • Cimminiello, Michele;
    • Zanotti, Roberta;
    • Farina, Lucia;
    • Ferreri, Andrés José Maria;
    • Galbiati, Marina;
    • Corradini, Paolo;
    • Gianni, Alessandro Massimo;
    • Gallamini, Andrea
    Publication type:
    Article
    5
    6
    7
    8

    Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim <sup>18</sup>F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.

    Published in:
    Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 410, doi. 10.23736/S1824-4785.17.02993-4
    By:
    • BIGGI, Alberto;
    • BERGESIO, Fabrizio;
    • CHAUVIE, Stephane;
    • BIANCHI, Andrea;
    • MENGA, Massimo;
    • FALLANCA, Federico;
    • HUTCHINGS, Martin;
    • GREGIANIN, Michele;
    • MEIGNAN, Michel;
    • GALLAMINI, Andrea
    Publication type:
    Article
    9

    HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S371, doi. 10.1016/S2152-2650(21)01849-8
    By:
    • Ramchandren, Radhakrishnan;
    • Dfugosz-Danecka, Monika;
    • Connors, Joseph M.;
    • Radford, John;
    • Illés, Árpád;
    • Picardi, Marco;
    • Lech-Maranda, Ewa;
    • Feldman, Tatyana;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Hutchings, Martin;
    • Munoz, Javier;
    • Won Seog Kim;
    • Advani, Ranjana;
    • Ansell, Stephen M.;
    • Gallamini, Andrea;
    • Alekseev, Sergey
    Publication type:
    Article
    10

    Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S236, doi. 10.1016/S2152-2650(21)01485-3
    By:
    • Ramchandren, Radhakrishnan;
    • Długosz-Danecka, Monika;
    • Connors, Joseph M.;
    • Radford, John;
    • Illés, Árpád;
    • Picardi, Marco;
    • Lech-Maranda, Ewa;
    • Feldman, Tatyana;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Hutchings, Martin;
    • Munoz, Javier;
    • Won Seog Kim;
    • Advani, Ranjana;
    • Ansell, Stephen M.;
    • Gallamini, Andrea;
    • Alekseev, Sergey
    Publication type:
    Article
    11

    The Prognostic Value of the Myeloid-Mediated Immunosuppression Marker Arginase-1 in Classic Hodgkin Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2016, v. 16, p. S66, doi. 10.1016/j.clml.2016.07.096
    By:
    • Romano, Alessandra;
    • Parrinello, Nunziatina;
    • Vetro, Calogero;
    • Tibullo, Daniele;
    • Giallongo, Cesarina;
    • La Cava, Piera;
    • Chiarenza, Annalisa;
    • Motta, Giovanna;
    • Caruso, Anastasia;
    • Villari, Loredana;
    • Tripodo, Claudio;
    • Cosentino, Sebastiano;
    • Ippolito, Massimo;
    • Consoli, Ugo;
    • Gallamini, Andrea;
    • Pileri, Stefano;
    • Di Raimondo, Francesco
    Publication type:
    Article
    12

    Chemoresistance as a function of the pretherapy tumor burden and the chemotherapy regimen administered: differences observed with 2 current chemotherapy regimens for advanced Hodgkin lymphoma.

    Published in:
    2011
    By:
    • Gobbi, Paolo G.;
    • Valentino, Francesco;
    • Bassi, Emilio;
    • Coriani, Chiara;
    • Merli, Francesco;
    • Bonfante, Valeria;
    • Marchianò, Alfonso;
    • Gallamini, Andrea;
    • Bolis, Silvia;
    • Stelitano, Caterina;
    • Levis, Alesssandro;
    • Federico, Massimo;
    • Angrilli, Francesco;
    • Di Giulio, Giuseppe;
    • Corazza, Gino R.
    Publication type:
    Journal Article
    13

    Chemoresistance As a Function of the Pretherapy Tumor Burden and the Chemotherapy Regimen Administered: Differences Observed With 2 Current Chemotherapy Regimens for Advanced Hodgkin Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 5, p. 396, doi. 10.1016/j.clml.2011.04.008
    By:
    • Gobbi, Paolo G.;
    • Valentino, Francesco;
    • Bassi, Emilio;
    • Coriani, Chiara;
    • Merli, Francesco;
    • Bonfante, Valeria;
    • Marchianò, Alfonso;
    • Gallamini, Andrea;
    • Bolis, Silvia;
    • Stelitano, Caterina;
    • Levis, Alessandro;
    • Federico, Massimo;
    • Angrilli, Francesco;
    • Di Giulio, Giuseppe;
    • Corazza, Gino R.
    Publication type:
    Article
    14

    Clinical relevance of immunophenotype in a retrospective comparative study of 297 peripheral T‐cell lymphomas, unspecified, and 496 diffuse large B‐cell lymphomas: Experience of the Intergruppo Italiano LinfomiInstitutions participating in the Intergruppo Italiano Linfomi study of peripheral T‐cell lymphoma include the following (principal investigators are listed in parentheses): Struttura Complessa di Ematologia, Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy (A. Gallamini, D. Mattei, and R. Calvi); Struttura Complessa di Ematologia, Azienda Ospedaliera San Giovanni Battista, Turin, Italy (E. Gallo and U. Vitolo); Cattedra di Ematologia, Università degli Studi di Torino, Turin, Italy (M. Boccadoro, C. Tarella, and M. Ladetto); Divisione di Onco‐Ematologia, Istituto di Ricovero a Carattere Scientifico Candiolo, Turin, Italy (M. Aglietta and D. Rota Scalabrini); Struttura Complessa di Medicina, Ospedale di Biella, Biella, Italy (S. Fontana and A. Tonso); Struttura Complessa di M

    Published in:
    Cancer (0008543X), 2004, v. 101, n. 7, p. 1601, doi. 10.1002/cncr.20531
    By:
    • Fortunato Morabito;
    • Andrea Gallamini;
    • Caterina Stelitano;
    • Vincenzo Callea;
    • Cesare Guglielmi;
    • Santo Neri;
    • Antonio Lazzaro;
    • Lorella Orsucci;
    • Fiorella Ilariucci;
    • Stefano Sacchi;
    • Umberto Vitolo;
    • Massimo Federico
    Publication type:
    Article
    15

    High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma.

    Published in:
    Cancer (0008543X), 2003, v. 97, n. 11, p. 2748
    By:
    • Corrado Tarella;
    • Alessandra Cuttica;
    • Umberto Vitolo;
    • Marina Liberati;
    • Massimo Di Nicola;
    • Sergio Cortelazzo;
    • Rosalba Rosato;
    • Carlo Rosanelli;
    • Nicola Di Renzo;
    • Maurizio Musso;
    • Enzo Pavone;
    • Gino Santini;
    • Alessandra Pescarollo;
    • Alberto De Crescenzo;
    • Massimo Federico;
    • Andrea Gallamini;
    • Patrizia Pregno;
    • Roberta Romano;
    • Paolo Coser;
    • Eugenio Gallo
    Publication type:
    Article
    16

    Low plasma cell 3(H) thymidine incorporation in monoclonal gammopathy of undetermined significance (MGUS), smouldering myeloma and remission phase myeloma: a reliable indicator of patients not requiring therapy.

    Published in:
    British Journal of Haematology, 1984, v. 58, n. 4, p. 689, doi. 10.1111/j.1365-2141.1984.tb06116.x
    By:
    • Boccadoro, Mario;
    • Gavarotti, Paolo;
    • Fossati, Giorgio;
    • Pileri, Alessandro;
    • Marmont, Filippo;
    • Neretto, Giorgio;
    • Gallamini, Andrea;
    • Volta, Carla;
    • Tribalto, Maurizio;
    • Testa, Maria G.;
    • Amadori, Sergio;
    • Mandelli, Franco;
    • Durie, Brian G. M.
    Publication type:
    Article
    17

    International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1343, doi. 10.2967/jnumed.124.267789
    By:
    • Boellaard, Ronald;
    • Buvat, Irène;
    • Nioche, Christophe;
    • Ceriani, Luca;
    • Cottereau, Anne-Ségolène;
    • Guerra, Luca;
    • Hicks, Rodney J.;
    • Kanoun, Salim;
    • Kobe, Carsten;
    • Loft, Annika;
    • Schöder, Heiko;
    • Versari, Annibale;
    • Voltin, Conrad-Amadeus;
    • Zwezerijnen, Gerben J.C.;
    • Zijlstra, Josée M.;
    • Mikhaeel, N. George;
    • Gallamini, Andrea;
    • El-Galaly, Tarec C.;
    • Hanoun, Christine;
    • Chauvie, Stephane
    Publication type:
    Article
    18

    Michel Meignan, MD, PhD, 1947-2022.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 342
    By:
    • Barrington, Sally;
    • Buvat, Irèene;
    • Cottereau, Anne-Ségolène;
    • Gallamini, Andrea;
    • Thieblemont, Catherine
    Publication type:
    Article
    19

    Richard C. Reba, MD, 1932-2022.

    Published in:
    Journal of Nuclear Medicine, 2023, v. 64, n. 2, p. 342
    By:
    • Barrington, Sally;
    • Buvat, Irèene;
    • Cottereau, Anne-Ségolène;
    • Gallamini, Andrea;
    • Thieblemont, Catherine
    Publication type:
    Article
    20
    21
    22
    23
    24
    25
    26
    27

    Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 5, p. 712, doi. 10.1007/s00259-017-3909-8
    By:
    • Nanni, Cristina;
    • Versari, Annibale;
    • Chauvie, Stephane;
    • Bertone, Elisa;
    • Bianchi, Andrea;
    • Rensi, Marco;
    • Bellò, Marilena;
    • Gallamini, Andrea;
    • Patriarca, Francesca;
    • Gay, Francesca;
    • Gamberi, Barbara;
    • Ghedini, Pietro;
    • Cavo, Michele;
    • Fanti, Stefano;
    • Zamagni, Elena
    Publication type:
    Article
    28

    Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 3, p. 414, doi. 10.1007/s00259-015-3200-9
    By:
    • Nanni, Cristina;
    • Zamagni, Elena;
    • Versari, Annibale;
    • Chauvie, Stephane;
    • Bianchi, Andrea;
    • Rensi, Marco;
    • Bellò, Marilena;
    • Rambaldi, Ilaria;
    • Gallamini, Andrea;
    • Patriarca, Francesca;
    • Gay, Francesca;
    • Gamberi, Barbara;
    • Cavo, Michele;
    • Fanti, Stefano
    Publication type:
    Article
    29

    FDG PET/CT imaging as a biomarker in lymphoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 4, p. 623, doi. 10.1007/s00259-014-2973-6
    By:
    • Meignan, Michel;
    • Itti, Emmanuel;
    • Gallamini, Andrea;
    • Younes, Anas
    Publication type:
    Article
    30

    Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 11, p. 2017, doi. 10.1007/s00259-014-2822-7
    By:
    • Sasanelli, Myriam;
    • Meignan, Michel;
    • Haioun, Corinne;
    • Berriolo-Riedinger, Alina;
    • Casasnovas, René-Olivier;
    • Biggi, Alberto;
    • Gallamini, Andrea;
    • Siegel, Barry;
    • Cashen, Amanda;
    • Véra, Pierre;
    • Tilly, Hervé;
    • Versari, Annibale;
    • Itti, Emmanuel
    Publication type:
    Article
    31

    An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2013, v. 40, n. 9, p. 1312, doi. 10.1007/s00259-013-2435-6
    By:
    • Itti, Emmanuel;
    • Meignan, Michel;
    • Berriolo-Riedinger, Alina;
    • Biggi, Alberto;
    • Cashen, Amanda F.;
    • Véra, Pierre;
    • Tilly, Hervé;
    • Siegel, Barry A.;
    • Gallamini, Andrea;
    • Casasnovas, René-Olivier;
    • Haioun, Corinne
    Publication type:
    Article
    32

    Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 10, p. 1824, doi. 10.1007/s00259-010-1490-5
    By:
    • Barrington, Sally;
    • Qian, Wendi;
    • Somer, Edward J.;
    • Franceschetto, Antonella;
    • Bagni, Bruno;
    • Brun, Eva;
    • Almquist, Helén;
    • Loft, Annika;
    • Højgaard, Liselotte;
    • Federico, Massimo;
    • Gallamini, Andrea;
    • Smith, Paul;
    • Johnson, Peter;
    • Radford, John;
    • O'Doherty, Michael J.
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.

    Published in:
    2007
    By:
    • Rigacci, Luigi;
    • Vitolo, Umberto;
    • Nassi, Luca;
    • Merli, Francesco;
    • Gallamini, Andrea;
    • Pregno, Patrizia;
    • Alvarez, Isabel;
    • Salvi, Flavia;
    • Sancetta, Rosaria;
    • Castagnoli, Antonio;
    • Versari, Annibale;
    • Biggi, Alberto;
    • Gregianin, Michele;
    • Pelosi, Ettore;
    • Chisesi, Teodoro;
    • Bosi, Alberto;
    • Levis, Alessandro;
    • Intergruppo Italiano Linfomi
    Publication type:
    journal article
    39

    Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses.

    Published in:
    British Journal of Haematology, 2011, v. 152, n. 5, p. 551, doi. 10.1111/j.1365-2141.2010.08485.x
    By:
    • Gallamini, Andrea;
    • Patti, Caterina;
    • Viviani, Simonetta;
    • Rossi, Andrea;
    • Fiore, Francesca;
    • Di Raimondo, Francesco;
    • Cantonetti, Maria;
    • Stelitano, Caterina;
    • Feldman, Tatyana;
    • Gavarotti, Paolo;
    • Sorasio, Roberto;
    • Mulè, Antonino;
    • Leone, Monica;
    • Rambaldi, Alessandro;
    • Biggi, Alberto;
    • Barrington, Sally;
    • Fallanca, Federico;
    • Ficola, Umberto;
    • Chauvie, Stéphane;
    • Gianni, Alessandro Massimo
    Publication type:
    Article
    40

    WIDEN: A tool for medical image management in multicenter clinical trials.

    Published in:
    Clinical Trials, 2014, v. 11, n. 3, p. 355, doi. 10.1177/1740774514525690
    By:
    • Chauvie, Stéphane;
    • Biggi, Alberto;
    • Stancu, Alexandru;
    • Cerello, Piergiorgio;
    • Cavallo, Anna;
    • Fallanca, Federico;
    • Ficola, Umberto;
    • Gregianin, Michele;
    • Guerra, Ugo Paolo;
    • Chiaravalloti, Agostino;
    • Schillaci, Orazio;
    • Gallamini, Andrea
    Publication type:
    Article
    41

    A Score-Based Approach to <sup>18</sup>F-FDG PET Images as a Tool to Describe Metabolic Predictors of Myocardial Doxorubicin Susceptibility.

    Published in:
    Diagnostics (2075-4418), 2017, v. 7, n. 4, p. 57, doi. 10.3390/diagnostics7040057
    By:
    • Bauckneht, Matteo;
    • Morbelli, Silvia;
    • Fiz, Francesco;
    • Ferrarazzo, Giulia;
    • Piva, Roberta;
    • Nieri, Alberto;
    • Sarocchi, Matteo;
    • Spallarossa, Paolo;
    • Canepari, Maria Elisa;
    • Arboscello, Eleonora;
    • Bellodi, Andrea;
    • Massaia, Massimo;
    • Gallamini, Andrea;
    • Bruzzi, Paolo;
    • Marini, Cecilia;
    • Sambuceti, Gianmario
    Publication type:
    Article
    42

    Role of PET in Lymphoma.

    Published in:
    Current Treatment Options in Oncology, 2014, v. 15, n. 2, p. 248, doi. 10.1007/s11864-014-0278-4
    By:
    • Gallamini, Andrea;
    • Borra, Anna
    Publication type:
    Article
    43
    44
    45

    Primary nodal marginal zone B-cell lymphoma: clinical features and prognostic assessment of a rare disease.

    Published in:
    British Journal of Haematology, 2007, v. 136, n. 2, p. 301, doi. 10.1111/j.1365-2141.2006.06437.x
    By:
    • Arcaini, Luca;
    • Paulli, Marco;
    • Burcheri, Sara;
    • Rossi, Andrea;
    • Spina, Michele;
    • Passamonti, Francesco;
    • Lucioni, Marco;
    • Motta, Teresio;
    • Canzonieri, Vincenzo;
    • Montanari, Mauro;
    • Bonoldi, Emanuela;
    • Gallamini, Andrea;
    • Uziel, Lilj;
    • Crugnola, Monica;
    • Ramponi, Antonio;
    • Montanari, Francesca;
    • Pascutto, Cristiana;
    • Morra, Enrica;
    • Lazzarino, Mario
    Publication type:
    Article
    46
    47

    The prognostic value of positron emission tomography performed after two courses ( INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL).

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 6, p. 499, doi. 10.1002/ajh.23994
    By:
    • Rigacci, Luigi;
    • Puccini, Benedetta;
    • Zinzani, Pier Luigi;
    • Biggi, Alberto;
    • Castagnoli, Antonio;
    • Merli, Francesco;
    • Balzarotti, Monica;
    • Stelitano, Caterina;
    • Spina, Michele;
    • Vitolo, Umberto;
    • Stefoni, Vittorio;
    • Levis, Alessandro;
    • Gotti, Manuel;
    • Rosaria, Sancetta;
    • Maria, Stefani Piero;
    • Bosi, Alberto;
    • Gallamini, Andrea
    Publication type:
    Article
    48

    Primary prophylaxis with G-CSF may improve outcomes in patients with newly diagnosed stage III/IV Hodgkin lymphoma treated with brentuximab vedotin plus chemotherapy.

    Published in:
    Leukemia & Lymphoma, 2020, v. 61, n. 12, p. 2931, doi. 10.1080/10428194.2020.1791846
    By:
    • Straus, David;
    • Collins, Graham;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Grigg, Andrew;
    • Sureda, Anna;
    • Illes, Arpad;
    • Kim, Tae Min;
    • Alekseev, Sergey;
    • Specht, Lena;
    • Buccheri, Valeria;
    • Younes, Anas;
    • Connors, Joseph;
    • Forero-Torres, Andres;
    • Fenton, Keenan;
    • Gautam, Ashish;
    • Purevjal, Indra;
    • Liu, Rachael;
    • Gallamini, Andrea
    Publication type:
    Article
    49
    50

    Abstracts from the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 5, p. 1233, doi. 10.3109/10428194.2015.1034707
    By:
    • Zwarthoed, Cholette;
    • Ouvier, Matthieu John;
    • Borra, Anna;
    • Bergesio, Fabrizio;
    • Chauvie, Stephane;
    • Biggi, Alberto;
    • Hutchings, Martin;
    • El-Galaly, Tarek;
    • Gallamini, Andrea;
    • Simon, Zsófia;
    • Miltényi, Zsófia;
    • Magyari, Ferenc;
    • Barna, Sándor;
    • Kenyeres, Anna;
    • Jóna, Ádám;
    • Illés, Árpád;
    • Dann, Eldad J.;
    • Bar-Shalom, Rachel;
    • Kagana, Olga;
    • Bairey, Osnat
    Publication type:
    Article